BRPI0923161A2 - "dispositivo implantável" - Google Patents

"dispositivo implantável"

Info

Publication number
BRPI0923161A2
BRPI0923161A2 BRPI0923161A BRPI0923161A BRPI0923161A2 BR PI0923161 A2 BRPI0923161 A2 BR PI0923161A2 BR PI0923161 A BRPI0923161 A BR PI0923161A BR PI0923161 A BRPI0923161 A BR PI0923161A BR PI0923161 A2 BRPI0923161 A2 BR PI0923161A2
Authority
BR
Brazil
Prior art keywords
implantable device
implantable
Prior art date
Application number
BRPI0923161A
Other languages
English (en)
Inventor
Deborah M Schachter
Han Cui
Lieven Elvire Colette Baert
Qiang Zhang
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of BRPI0923161A2 publication Critical patent/BRPI0923161A2/pt
Publication of BRPI0923161B1 publication Critical patent/BRPI0923161B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
BRPI0923161A 2008-12-24 2009-12-24 dispositivo implantável de uma peça contendo rilpivirina BRPI0923161B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14069408P 2008-12-24 2008-12-24
PCT/EP2009/067933 WO2010072844A1 (en) 2008-12-24 2009-12-24 Implantable devices for treating hiv

Publications (2)

Publication Number Publication Date
BRPI0923161A2 true BRPI0923161A2 (pt) 2016-02-10
BRPI0923161B1 BRPI0923161B1 (pt) 2019-01-15

Family

ID=42167643

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0923161A BRPI0923161B1 (pt) 2008-12-24 2009-12-24 dispositivo implantável de uma peça contendo rilpivirina

Country Status (18)

Country Link
US (3) US20110256206A1 (pt)
EP (1) EP2381961B1 (pt)
JP (1) JP5612602B2 (pt)
KR (1) KR101726615B1 (pt)
CN (1) CN102711834B (pt)
AU (1) AU2009332910B2 (pt)
BR (1) BRPI0923161B1 (pt)
CA (1) CA2747955C (pt)
ES (1) ES2607107T3 (pt)
HK (1) HK1172842A1 (pt)
IL (1) IL213542A (pt)
MX (1) MX2011006856A (pt)
MY (1) MY160360A (pt)
NZ (1) NZ593950A (pt)
RU (1) RU2546529C2 (pt)
SG (2) SG172398A1 (pt)
WO (1) WO2010072844A1 (pt)
ZA (1) ZA201104669B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8784858B2 (en) 2009-12-21 2014-07-22 Janssen R&D Ireland Degradable removable implant for the sustained release of an active compound
US9423528B2 (en) 2012-06-25 2016-08-23 Johnson & Johnson Vision Care, Inc. Method of making silicone containing contact lens with reduced amount of diluents
US20130341811A1 (en) * 2012-06-25 2013-12-26 Johnson & Johnson Vision Care, Inc. Lens comprising low and high molecular weight polyamides
JP6835841B2 (ja) * 2015-11-16 2021-02-24 エボニック オペレーションズ ゲーエムベーハー 非核酸系逆転写酵素阻害剤とポリ(ラクチド−co−グリコリド)とを含む注射液
RU2755130C2 (ru) * 2016-05-12 2021-09-13 Мерк Шарп И Доум Корп. Система доставки лекарств для доставки противовирусных средств

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743446B2 (en) * 1999-12-15 2004-06-01 The Ohio State University Research Foundation Methods for stabilizing biologically active agents encapsulated in biodegradable controlled-release polymers
WO2001065911A2 (en) * 2000-03-03 2001-09-13 Valentis, Inc. Improved poloxamer and poloxamine compositions for nucleic acid delivery
MY169670A (en) * 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
JO3429B1 (ar) 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
DE10212864B4 (de) * 2002-03-22 2005-12-22 Beiersdorf Ag Polymermatrizes umfassend ein Mischsystem zur Löslichkeitsvermittlung von pharmazeutischen Wirkstoffen, Verfahren zu deren Herstellung und deren Verwendung
US7201925B2 (en) * 2002-04-23 2007-04-10 Nueryst Pharmaceuticals Corp. Treatment of ungual and subungual diseases
CN1290893C (zh) 2002-05-03 2006-12-20 詹森药业有限公司 聚合物微乳状液
US20060003008A1 (en) * 2003-12-30 2006-01-05 Gibson John W Polymeric devices for controlled release of active agents
AU2005304435B8 (en) * 2004-11-10 2011-06-23 Tolmar Therapeutics, Inc. A stabilized polymeric delivery system
TWI457136B (zh) * 2005-04-04 2014-10-21 Tibotec Pharm Ltd Hiv-感染之預防
WO2006131806A2 (en) * 2005-06-07 2006-12-14 Pfizer Products Inc. Multiparticulates comprising low-solubility drugs and carriers that result in rapid drug release
SI1981506T1 (sl) * 2006-01-20 2013-08-30 Janssen R&D Ireland Dolgoročno zdravljenje infekcije HIV s TCM278
MX2009000158A (es) * 2006-06-23 2009-01-23 Tibotec Pharm Ltd Suspensiones acuosas de 4-[[4-[[4-(2-cianoetenil)-2,6-dimetilfenil ]-amino]-2-pirimidinil]-amino]-benzonitrilo.

Also Published As

Publication number Publication date
IL213542A (en) 2017-02-28
MX2011006856A (es) 2011-08-03
CN102711834A (zh) 2012-10-03
HK1172842A1 (zh) 2013-05-03
JP2012513969A (ja) 2012-06-21
MY160360A (en) 2017-02-28
BRPI0923161B1 (pt) 2019-01-15
NZ593950A (en) 2013-08-30
ZA201104669B (en) 2018-11-28
IL213542A0 (en) 2011-07-31
CN102711834B (zh) 2015-08-26
AU2009332910A1 (en) 2011-07-07
ES2607107T3 (es) 2017-03-29
RU2011130557A (ru) 2013-01-27
CA2747955C (en) 2017-06-13
EP2381961A1 (en) 2011-11-02
US20220079875A1 (en) 2022-03-17
KR20110117100A (ko) 2011-10-26
EP2381961B1 (en) 2016-09-14
SG196774A1 (en) 2014-02-13
US20110256206A1 (en) 2011-10-20
AU2009332910B2 (en) 2015-10-15
WO2010072844A1 (en) 2010-07-01
KR101726615B1 (ko) 2017-04-13
CA2747955A1 (en) 2010-07-01
US20180235872A1 (en) 2018-08-23
SG172398A1 (en) 2011-07-28
JP5612602B2 (ja) 2014-10-22
RU2546529C2 (ru) 2015-04-10

Similar Documents

Publication Publication Date Title
BRPI0720347A2 (pt) dispositivo implantável
BRPI0916125A2 (pt) "dispositivo de tratamento"
FR2931076B1 (fr) Dispositif implantable sous-cutane
BRPI1010909A2 (pt) "inseticida arilpirrolinas"
BRPI0910229A2 (pt) Tetramatos de 4';4'-dioxaspiro espirociclicamente substituídos
BR112012012872A2 (pt) "pirrolindinas de espiroindolinona"
BRPI1013015A2 (pt) "osteosíntese com nanoprata"
BRPI0922904A2 (pt) "compostos"
BRPI0915879A2 (pt) dispositivos médicos temporariamente posicionáveis
BRPI0916931A2 (pt) agentes terapêuticos
GB0808005D0 (en) "Device"
DK2185142T3 (da) Antiseptiske midler
BRPI0915822A2 (pt) dispositivo médico
BRPI0914533A2 (pt) "métodos"
BRPI0919748A2 (pt) dipositivo de tratamento
DK3150178T3 (da) Stimuleringsapparat
BRPI0812231A2 (pt) Dispositivo cirúrgico
DK2173831T3 (da) Brøndbehandling
FR2933861B3 (fr) Dispositif d'avancee mandibulaire ameliore
ITMI20080346A1 (it) "dispositivo di frenatura"
SMT201600041B (it) Agenti terapeutici 713
DK2520149T3 (da) Slåindretning
BRPI0716374A2 (pt) "dispositivos médicos"
BRPI1006038A2 (pt) "dispositivo de acionamento"
BRPI0912810A2 (pt) "filtro"

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: JANSSEN RANDD IRELAND (IE)

B25A Requested transfer of rights approved

Owner name: JANSSEN SCIENCES IRELAND UC (IE)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/12/2009, OBSERVADAS AS CONDICOES LEGAIS.